Longitude Capital is a healthcare-focused venture capital firm founded in 2006 and headquartered in Menlo Park, California, with an additional office in Boston, Massachusetts, specializing in venture growth investments in biotechnology, medical technology, and health solutions companies. The firm was formed following its founding team's spin-out from Pequot Capital, where they had built a life sciences investment practice since 1997, and the founders have been investing together since 2002 with over 200 years of combined life sciences investing experience. Longitude has raised over $2 billion across six funds and has made over 179 investments with more than 113 exits, targeting clinical-stage and commercial-stage companies with clinically de-risked assets and a mission of improving clinical outcomes, enhancing patient quality of life, and reducing healthcare costs. Notable portfolio investments include Jazz Pharmaceuticals, Corcept Therapeutics, NxStage Medical, Axonics Modulation Technologies, PROCEPT BioRobotics, and Kestra Medical Technologies.